Wetherby Asset Management Inc. Purchases 88 Shares of Henry Schein, Inc. (NASDAQ:HSIC)
Wetherby Asset Management Inc. boosted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.8% during the second quarter, according to its most recent filing with the SEC. The firm owned 3,235 shares of the company’s stock after buying an additional 88 shares during the period. Wetherby Asset Management Inc.’s holdings in Henry Schein were worth $592,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. SpiderRock Advisors LLC purchased a new position in Henry Schein during the first quarter valued at about $102,000. Lee Financial Co purchased a new position in Henry Schein during the second quarter valued at about $161,000. JNBA Financial Advisors purchased a new position in Henry Schein during the first quarter valued at about $170,000. Westside Investment Management Inc. purchased a new position in Henry Schein during the first quarter valued at about $168,000. Finally, Peddock Capital Advisors LLC boosted its position in Henry Schein by 29.1% in the first quarter. Peddock Capital Advisors LLC now owns 1,097 shares of the company’s stock valued at $186,000 after buying an additional 247 shares in the last quarter. Institutional investors and hedge funds own 90.87% of the company’s stock.
Henry Schein, Inc. (HSIC) opened at 170.58 on Friday. The company has a market cap of $13.49 billion, a PE ratio of 24.93 and a beta of 1.09. Henry Schein, Inc. has a one year low of $146.23 and a one year high of $186.99. The firm’s 50-day moving average price is $181.54 and its 200-day moving average price is $175.12.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The firm had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. During the same quarter in the previous year, the company posted $1.64 EPS. The business’s revenue was up 6.4% on a year-over-year basis. On average, equities research analysts forecast that Henry Schein, Inc. will post $7.28 earnings per share for the current fiscal year.
Several equities analysts recently issued reports on the company. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating in a report on Wednesday. BidaskClub cut Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, August 2nd. Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price target on the stock in a report on Monday, August 7th. Jefferies Group LLC reiterated a “hold” rating and issued a $177.00 price target on shares of Henry Schein in a report on Friday, July 21st. Finally, Credit Suisse Group reiterated a “hold” rating and issued a $160.00 price target on shares of Henry Schein in a report on Thursday, July 13th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $185.56.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.